(Q34264508)

1 August 2017

0 references

Recent developments in the treatment of cachexia: highlights from the 6th Cachexia Conference (English)

1 reference

Erratum to: Recent developments in the treatment of cachexia: highlights from the 6th Cachexia Conference

1 August 2017

corrigendum / erratum

0 references

5

Stephan von Haehling

1 reference

1 August 2017

4

Stefan D Anker

1 reference

1 August 2017

3

Wolfram Doehner

1 reference

1 August 2017

2

Claudia G Werner

1 reference

1 August 2017

Nicole Ebner

1

1 reference

1 August 2017

publication date

2 March 2012

1 reference

Journal of Cachexia, Sarcopenia and Muscle

1 August 2017

published in

1 reference

1 August 2017

volume

3

1 reference

1 August 2017

issue

1

1 reference

1 August 2017

page(s)

45-50

1 reference

The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal c

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302986

The 6th Cachexia Conference: an introduction to clinical and basic research in an exiting area

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302986

The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302986

Breakthrough in cachexia treatment through a novel selective androgen receptor modulator?!

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302986

Muscle actin is polyubiquitinylated in vitro and in vivo and targeted for breakdown by the E3 ligase MuRF1.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302986

mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302986

Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302986

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302986

Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302986

Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302986

An overview of sarcopenia: facts and numbers on prevalence and clinical impact

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302986

Myopenia-a new universal term for muscle wasting

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302986

Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302986

Cachexia: a new definition

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302986

Ghrelin, a novel growth hormone-releasing peptide, in the treatment of chronic heart failure

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302986

Ghrelin improves left ventricular dysfunction and cardiac cachexia in heart failure

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3302986

Mechanisms underlying the sparing of masticatory versus limb muscle function in an experimental critical illness model

6 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22460618

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13539-012-0061-Y

1 reference

1 August 2017

1 reference

1 August 2017

1 reference